kabutan

SanBio, Net Income Forecast for the Fiscal Year Loss to Narrow

Wed May 13, 2026 12:00 pm JST Revision

4592 SanBio Company Limited 【J-GAAP】

Guidance Update Report

SanBio Company Limited <4592> [TSE Growth] announced a performance revision at noon (12:00) on May 13th. The consolidated net income/loss forecast for the fiscal year ending January 2027 has been revised upward from an expected loss of 5.63 billion yen to a loss of 5.13 billion yen (compared to a loss of 3.84 billion yen in the previous period), indicating a reduction in the loss margin.

Furthermore, the February to July period (first half) consolidated net income/loss forecast remains unchanged from the estimate of loss of 2.90 billion yen(compared to a loss of 1.99 billion yen in the previous period).

Kabutan News

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan, 2027 Prev -5,625 -5,632 -5,635 -72.2 0 Mar 17, 2026 J-GAAP
Jan, 2027 New 396 -5,229 -5,074 -5,133 -65.8 0 May 13, 2026 J-GAAP
Revision Rate +7.0% +9.9% +8.9% +8.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2025 0 -1,888 -2,481 -1,997 -27.8 0 Sep 12, 2025 J-GAAP
Feb - Jul, 2026 Guidance 0 -2,906 -2,908 -2,909 -37.3 0 Mar 17, 2026 J-GAAP
YoY -53.9% -17.2% -45.7% -34.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan, 2025 0 -3,516 -3,022 -2,882 -41.9 0 Mar 17, 2025 J-GAAP
Jan, 2026 0 -3,794 -4,291 -3,842 -52.6 0 Mar 17, 2026 J-GAAP
Jan, 2027 Guidance 396 -5,229 -5,074 -5,133 -65.8 0 May 13, 2026 J-GAAP
YoY -37.8% -18.2% -33.6% -25.1%

Related Articles